30 अक्टूबर 2026 को 12:30 pm बजे UTC
Public meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee, announced by the FDA in the Federal Register on 2026-09-25. Topic: New Drug Application (NDA) 219694 for Atropine Sulfate Ophthalmic Solution, 0.01%. Times are as stated in the notice (Eastern Time).
FDA सलाहकार समिति की बैठकें कैलेंडर